Ardelyx

ARDXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$988.118 M

$4.00 -17.86%

Close of 7 Aug 2026

Revenue

$407.3M

#2019 by revenue

Earnings

-$62.0M

Loss-making

Shares outstanding

249,187,572

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#160Opko HealthOPK$1.02B
#161Pacira BioSciencesPCRX$997.3M
#162ArdelyxARDX$988.1M
#163Avalo TherapeuticsAVTX$969.2M
#164Adlai NortyeANL$967.6M

Where these numbers come from

Share counts and financials for Ardelyx are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.